期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Ⅰ型心肾综合征的诊断标准及心肾损害的生物标志物 被引量：4

原文传递
导出
摘要 Ⅰ型心肾综合征的概念及诊断本文将重点讨论Ⅰ型心肾综合征（cardiorenal syndrome,CRS）的诊断问题,故需先对其概念及分型作一简介。
作者 王银娜 谌贻璞
机构地区 首都医科大学附属北京安贞医院肾内科
出处 《诊断学理论与实践》 2011年第3期192-194,共3页 Journal of Diagnostics Concepts & Practice
关键词 心肾综合征 肾脏损害 生物标志物 诊断
分类号 R692.9 [医药卫生—泌尿科学]
  • 相关文献

参考文献13

  • 1谌贻璞.心肾综合征：概念、分类与思考[J].中华内科杂志,2010,49(7):553-554. 被引量：22
  • 2Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative [J]. Eur Heart J,2010,31 (6):703-711.
  • 3Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome[J]. J Am Coll Cardiol,2008,52(19):1527-1539.
  • 4Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care,2007,11 (2): R31.
  • 5Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology [J]. Am J Roentgenol,2003,181 (6): 1463-1471.
  • 6McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-in- duced nephropathy [J]. Am J Cardiol,2006,98 (6A):5K- 13K.
  • 7Nunag M, Brogan M, Gan-ick It. Mitigating contrast-in- duced aeute kidney injury associated with cardiac catheterization[J]. Cardiol 1tev,2009,17(6):263-269.
  • 8Iwanaga Y, Miyazaki S. Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint[J]. Circ J,2010,74(7):1274-1282.
  • 9Maisel AS, Katz N, Hillege HL, et al. Biomarkers in kidney and heart disease [J]. Nephrol Dial Transplant, 2011,26(1):62-74.
  • 10Soni SS, Fahuan Y, Rouco C, et al. Cardiorenal syndrome: biomarkers linking kidney damage with heart failure[J]. Biomark Med,2009,3(5):549-560.

二级参考文献10

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量：183
  • 2Heywood J.The cardiorenal syndrome:lessons from the ADHERE database and treatment options.Heart Fail Rev,2004,9:195-201.
  • 3Ronco C,Haapio M,House AA,et al.Cardiorenal syndrome.J Am Coll Cardiol,2008,52:1527-1539.
  • 4Ronco C,House AA,Haapio M.Cardiorenal and renocardiac syndromes:the need for a comprehensive classification and consensus.Nat Clin Pract Nephrol,2008,4:310-311.
  • 5Ronco C,McCullough P,Anker SD,et al.Cardio-renal syndromes:report from the consensus conference of the acute dialysis quality initiative.Eur Heart J,2010,31:703-711.
  • 6Ronco C,Chionh CY,Haapio M,et al.The cardiorenal syndrome.Blood Purif,2009,27:114-126.
  • 7王玉.心力衰竭和心肾综合征//王海燕.肾脏病临床概览.北京:北京大学医学出版社,2010:353-358.
  • 8Wilson Tang WH,Mullens W.Cardiorenal syndrome in decompensated heart failure.Heart,2010,96:255-260.
  • 9Mahapatra HS,Lalmalsawma R,Singh NP,et al.Cardiorenal syndrome.Iran J Kidney Dis,2009,3:61-70.
  • 10Bongartz LG,Cramer MJ,Doevendans PA,et al.The severe cardiorenal syndrome:' Guyton revisited'.Eur Heart J,2005,26:11-17.

共引文献21

同被引文献47

  • 1张鹏,王前,郑磊,曾方银,裘宇容.心肌型脂肪酸结合蛋白早期诊断急性冠脉综合征[J].南方医科大学学报,2006,26(3):358-360. 被引量：11
  • 2吴光哲,张必利,郑兴,秦永文.慢性肾脏病与冠心病相关性的临床研究[J].心血管康复医学杂志,2006,15(5):447-450. 被引量：17
  • 3Lameire N, Van BW, Vanholder R. The changing epidemiology of acute renal failure[J]. Nat Clin Pract Nephrol, 2006, 2:364-377.
  • 4Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically illpatients:a multinational, multicenterstudy [J]. JA- MA, 2005, 294:813-818.
  • 5Mattes WB, Walker EC. Translational toxicology and thework of the predictive safety testing consortiu [J]. Clin Pharmacol Ther, 2009, 85:327-330.
  • 6Rouse RL, Zhang J, Stewart SR. Comparative profile of commer- cially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats [J]. Kidney Int, 2011, 79: 1186-1197.
  • 7Prozialeck WC, Edwards JR. Early biomarkers of cadmiumexpo- sure and nephrotoxicity[J]. Biometals, 2010, 23:795-809.
  • 8Ling W, Zhao HN, Ben H, et al. Urinary IL- 18 and NGAL as early predictive biomarkers in contrast-induced nephropathy 'after coronary angiography[J]. Nephron Clin Pract, 2008, 108:176-181.
  • 9Bachorzewska, Gajewska H, Malyszko J, et al. NGAL(neutrophil gelatinaseassociated lipocalin) and cystatin C:are they good pre- dictors of contrast nephropathy after percutaneous coronary inter- ventions in patients with stable angina and normal serum creati- nine? [J]. Int J Cardiol, 2008, 127:290-291.
  • 10Shavit L, Dolgoker I, Ivgi H, et al. Neutrophil gelatinase-associ-ated lipocalin as a predictor of complications and mortality in pa- tients undergoing non-cardiac major surgery [J]. Kidney Blood Press Res, 2011, 34:116-124.

引证文献4

二级引证文献15

诊断学理论与实践
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部